Monte Rosa Therapeutics, Inc. (GLUE)
10.31
-0.01
(-0.10%)
USD |
NASDAQ |
Oct 09, 16:00
10.30
-0.01
(-0.10%)
After-Hours: 20:00
Monte Rosa Therapeutics Price : 10.31 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 10.04 | 10.38 | 9.82 | 10.32 | 1.887M |
| Oct 07, 2026 | 9.84 | 10.75 | 9.68 | 10.17 | 2.082M |
| Oct 06, 2026 | 10.38 | 10.38 | 9.78 | 9.87 | 1.053M |
| Oct 05, 2026 | 10.56 | 10.59 | 10.04 | 10.27 | 1.749M |
| Oct 02, 2026 | 11.40 | 11.40 | 10.32 | 10.50 | 2.215M |
| Oct 01, 2026 | 12.15 | 12.26 | 11.07 | 11.26 | 2.869M |
| Sep 30, 2026 | 11.85 | 12.15 | 11.65 | 11.93 | 913959.0 |
| Sep 29, 2026 | 11.68 | 12.17 | 11.56 | 11.74 | 545068.0 |
| Sep 28, 2026 | 11.69 | 11.98 | 11.50 | 11.71 | 772655.0 |
| Sep 25, 2026 | 11.75 | 11.89 | 11.62 | 11.77 | 802136.0 |
| Sep 24, 2026 | 11.93 | 12.00 | 11.42 | 11.72 | 1.144M |
| Sep 23, 2026 | 12.60 | 12.61 | 11.70 | 11.89 | 1.176M |
| Sep 22, 2026 | 12.35 | 12.73 | 12.21 | 12.60 | 1.213M |
| Sep 21, 2026 | 12.20 | 12.32 | 12.06 | 12.26 | 1.128M |
| Sep 18, 2026 | 12.57 | 12.64 | 12.02 | 12.13 | 1.598M |
| Sep 17, 2026 | 12.84 | 13.02 | 12.43 | 12.60 | 1.388M |
| Sep 16, 2026 | 12.94 | 13.01 | 12.59 | 12.65 | 1.496M |
| Sep 15, 2026 | 13.84 | 13.88 | 12.87 | 12.99 | 1.265M |
| Sep 14, 2026 | 14.35 | 14.38 | 13.38 | 13.90 | 1.787M |
| Sep 11, 2026 | 14.24 | 14.74 | 13.88 | 14.07 | 1.174M |
| Sep 10, 2026 | 14.21 | 14.34 | 13.83 | 14.32 | 1.065M |
| Sep 09, 2026 | 14.28 | 14.87 | 14.13 | 14.26 | 1.146M |
| Sep 08, 2026 | 13.55 | 14.29 | 13.44 | 14.27 | 1.197M |
| Sep 04, 2026 | 14.12 | 14.31 | 13.79 | 13.84 | 804585.0 |
| Sep 03, 2026 | 14.50 | 14.59 | 14.06 | 14.38 | 672732.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 549.32 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Anika Therapeutics, Inc. | 19.58 |
| Savara, Inc. | 4.925 |
Price Related Metrics
| PS Ratio | 31.34 |
| Price to Book Value | 1.803 |
| Earnings Yield | -18.49% |
| Market Cap | 878.68M |